Breaking News
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% Upgrade now
Close

Gilead Sciences Inc (GILD)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
64.840 +1.850    +2.94%
04/10 - Delayed Data. Currency in EUR ( Disclaimer )
  • Volume: 385
  • Bid/Ask: 64.960 / 66.780
  • Day's Range: 64.390 - 65.130
Type:  Equity
Market:  Austria
ISIN:  US3755581036 
Gilead 64.840 +1.850 +2.94%

GILD Technical Analysis

 
Gilead share technical analysis data, signals range from strong buy, buy, neutral, sell to strong Sell. Assess a detailed technical analysis based on the buy/sell signals of moving averages (simple and exponential for a wide range of periods) and buy, sell, overbought, oversold or neutral signals of common chart indicators (including RSI, MACD and CCI). View the GILD stock analysis data across your chosen time frame.
Summary:Strong Buy
Moving Averages:Strong BuyBuy (10)Sell (2)
Technical Indicators:Strong BuyBuy (6)Sell (2)

Pivot PointsOct 05, 2022 08:35 GMT

Name S3 S2 S1 Pivot Points R1 R2 R3
Classic 62.630 62.810 62.900 63.080 63.170 63.350 63.440
Fibonacci 62.810 62.913 62.977 63.080 63.183 63.247 63.350
Camarilla 62.916 62.941 62.965 63.080 63.015 63.040 63.064
Woodie's 62.586 62.788 62.856 63.058 63.126 63.328 63.396
DeMark's - - 62.855 63.057 63.125 - -

Technical IndicatorsOct 05, 2022 08:35 GMT

Name Value Action
RSI(14) 51.687 Neutral
STOCH(9,6) 55.419 Buy
STOCHRSI(14) 55.587 Buy
MACD(12,26) 0.296 Buy
ADX(14) 30.738 Sell
Williams %R -40.130 Buy
CCI(14) -6.4220 Neutral
ATR(14) 1.0821 Less Volatility
Highs/Lows(14) 0.0000 Neutral
Ultimate Oscillator 56.517 Buy
ROC -0.062 Sell
Bull/Bear Power(13) 0.0840 Buy

Buy: 6

Sell: 2

Neutral: 3


Summary:Strong Buy

Moving AveragesOct 05, 2022 08:35 GMT

Period Simple Exponential
MA5 64.506
Buy
64.370
Buy
MA10 64.848
Sell
64.711
Buy
MA20 65.144
Sell
64.714
Buy
MA50 63.429
Buy
63.583
Buy
MA100 61.434
Buy
62.036
Buy
MA200 59.537
Buy
60.406
Buy

Buy: 10

Sell: 2


Summary:Strong Buy

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

GILD Comments

Write your thoughts about Gilead Sciences Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Oc Masai
Oc Masai Apr 27, 2021 7:54
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Good job GILD. bullish move forward
Ashraf Elgendy
Ashraf Elgendy Mar 07, 2021 13:03
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Kite, a unit of Gilead Sciences (GILD),has announced that theFDA has granted approval for its T cell immunotherapy Yescarta (axicabtagene ciloleucel) for a certain category of adults...
RM RM
RM RM Mar 01, 2021 21:53
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Up Again
Ken Laing
Ken Laing Oct 23, 2020 18:43
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Time to load up before the big rise coming next week
Iggy Maldon
Iggy Maldon Jul 30, 2020 20:22
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Classic pump n’ dump. What a shambles
RM RM
RM RM May 28, 2020 22:24
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Will reach above 95
Chili Daug
Chili Daug May 28, 2020 22:24
Saved. See Saved Items.
This comment has already been saved in your Saved Items
when? hahah
SAGAR AGARWAL
SAGAR AGARWAL May 15, 2020 14:52
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Good time to accumulate.
Khizer Malik
Khizer Malik May 14, 2020 11:04
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Gilead will be supplying remdesivir to 127 countries starting next week! Also backed by big government organisations including donald trump. Good investmenr
Willy Chin
Willy Chin Apr 23, 2020 18:14
Saved. See Saved Items.
This comment has already been saved in your Saved Items
High chance to be trading above 90, good long stock
Viktor Veselý
Viktor Veselý Apr 12, 2020 7:48
Saved. See Saved Items.
This comment has already been saved in your Saved Items
By Deena Beasley(Reuters) - More than two-thirds of severely ill COVID-19 patients saw their condition improve after treatment with remdesivir, an experimental drug being developed by Gilead Sciences Inc., according to new data based on patient observation.The analysis, published on Friday by the New England Journal of Medicine, does not detail what other treatments the 61 hospitalized patients were given and data on eight of them were not included -- in one case because of a dosing error.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email